# Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

> **NCT03904927** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 104 (actual)

## Conditions studied

- Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

## Interventions

- **OTHER:** Radiation, Surgery or Radiofrequency ablation
- **DRUG:** Systemic therapy

## Key facts

- **NCT ID:** NCT03904927
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2024-09-15
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03904927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03904927, "Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03904927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*